CASSIA SCHMID: Open Payments
NPI 1205539202 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 64 payments from 10 companies in 2025. Trend: 2023 $155 · 2024 $831 · 2025 $1,243
Food & beverage: $1,243
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $296 |
| ABBVIE INC. | 13 | $250 |
| E.R. Squibb & Sons, L.L.C. | 15 | $182 |
| Otsuka America Pharmaceutical, Inc. | 9 | $145 |
| Lundbeck LLC | 4 | $86 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Corium, LLC | 2 | $66 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| Alkermes, Inc. | 2 | $52 |
| Indivior Inc. | 2 | $42 |
Products named: CAPLYTA, VRAYLAR, REXULTI, COBENFY, FANAPT, Azstarys, Auvelity, ARISTADA.
Industry payments across FL — which companies pay providers there.
